Advertisement

Topics

Argentix Limited Company Profile

00:03 EDT 20th September 2017 | BioPortfolio

Argentix specialises in providing comprehensive commercialisation and business-structuring support to assist fledgling technology enterprises. Our aim is to help turn indigenous ideas into invention and innovation creating pipelines of support that take new ideas all the way from the workbench into globally competitive businesses of tomorrow.Our key objectives are enabling businesses to fund and manage rapid growth and change, increasing their competitiveness and exploiting commercial opportunities.



Argentix offers a wide range of services including:



Identifying and winning external Funding

Feasibility and Business Plan Reporting

IPR support

Pro Tem management

Personnel training and development

Strategic policy analysis

Property advice

Social and Economic Evaluations/Studies

Exploiting demanding market places

Location

Roslin Biocentre
Roslin
Midlothian
EH25 9PS
United States of America

Contact

Phone: 0131 440 4600
Fax: 0131 440 4647


News Articles [15 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Argentix Limited

Argentix specialises in providing comprehensive commercialisation and business-structuring support to assist fledgling technology enterprises. Our aim is to help turn indigenous ideas into invention a...

Argentix Ltd.

Argentix specialises in providing comprehensive commercialisation and business-structuring support to assist fledgling technology enterprises. Our aim is to help turn indigenous ideas into invention a...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Argentix Limited" on BioPortfolio

We have published hundreds of Argentix Limited news stories on BioPortfolio along with dozens of Argentix Limited Clinical Trials and PubMed Articles about Argentix Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argentix Limited Companies in our database. You can also find out about relevant Argentix Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record